Articles and Insights About Wearables for Clinical Trials

Articles by Shelby Bachman, PhD

Shelby Bachman, PhD

Shelby Bachman, PhD VivoSense Research Scientist, uses data from wearable sensors to develop real-world digital measures that can be deployed in clinical trials. Her academic background is in neuroscience and gerontology. During her PhD, she studied neural, physiological, and behavioral factors associated with successful aging. Shelby has extensive experience designing human-centered studies, collecting physiological data, and applying statistical methods to gather insights from complex datasets.

Find me on:

Recent Articles


Capturing Real-World Physical Behavior in Cancer Survivors

 Shelby Bachman, PhD

VivoSense Research Scientist Shelby Bachman, PhD, presented the poster, Real-world physical behavior is associated with aerobic fitness, but not patient-reported outcomes, in cancer survivors, at the October 22, 2023, Banff 9th Annual PROMIS International Conference, a multi-disciplinary forum for learning about the use of patient-reported outcome measures in clinical care and research. Shelby’s poster presentation summarized VivoSense’s recent work examining the clinical utility of real-world digital measures in oncology. Here's a quick snapshot of the poster content.

Read More

Assessing Physical Function with Wearable Sensors in Cancer Survivors

 Shelby Bachman, PhD

Research scientist Shelby Bachman, PhD, spoke at the Roche Digital Biomarkers in Clinical Trials Summit on the prospects for wearable sensors for measuring health-related quality of life in cancer survivors.

Read More

Digital Measures of Physical Behavior for Alzheimer's Clinical Trials

 Shelby Bachman, PhD

In collaboration with researchers at the University of Massachusetts Amherst, VivoSense published a new review paper in the Journal of Alzheimer’s Disease. The review summarizes how measures of real-world physical behavior, captured with digital health technologies, can contribute to more holistic assessment of functional independence in Alzheimer’s disease clinical research.

Read More
 Newer All Articles Older 

Stay Connected

Popular